Department of Biotechnology and Biomedicine, Technical University of Denmark, Søltofts Plads bldg. 221, DK-2800 Kgs Lyngby, Denmark.
Nat Prod Rep. 2019 Sep 1;36(9):1333-1350. doi: 10.1039/c9np00020h. Epub 2019 Sep 6.
Covering: up to 2019Humanity is in dire need for novel medicinal compounds with biological activities ranging from antibiotic to anticancer and anti-dementia effects. Recent developments in genome sequencing and mining have revealed an unappreciated potential for bioactive molecule production in marine Proteobacteria. Also, novel bioactive compounds have been discovered through molecular manipulations of either the original marine host bacteria or in heterologous hosts. Nevertheless, in contrast to the large repertoire of such molecules as predicted by in silico analysis, few marine bioactive compounds have been reported. This review summarizes the recent advances in the study of natural products from marine Proteobacteria. Here we present successful examples on genetic engineering of biosynthetic gene clusters of natural products from marine Proteobacteria. We also discuss the future prospects of discovering novel bioactive molecules via both heterologous production methodology and the development of marine Proteobacteria as new cell factories.
截至 2019 年人类急需具有从抗生素到抗癌和抗痴呆作用等生物活性的新型药物化合物。基因组测序和挖掘的最新进展揭示了海洋变形菌产生生物活性分子的未被充分认识的潜力。此外,通过对原始海洋宿主细菌或异源宿主的分子操作,也发现了新的生物活性化合物。然而,与通过计算机分析预测的大量此类分子相比,报道的海洋生物活性化合物却很少。本文综述了海洋变形菌天然产物研究的最新进展。在此,我们介绍了海洋变形菌天然产物生物合成基因簇遗传工程的成功范例。我们还讨论了通过异源生产方法和将海洋变形菌开发为新型细胞工厂来发现新型生物活性分子的未来前景。